Matthias Gerlach - AEZS Old Senior Production
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Executive
Matthias Gerlach is Senior Production of AEZS Old
| Phone | 843 900 3223 |
| Web | https://www.zentaris.com |
AEZS Old Management Efficiency
The company has return on total asset (ROA) of (0.2996) % which means that it has lost $0.2996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8171) %, meaning that it created substantial loss on money invested by shareholders. AEZS Old's management efficiency ratios could be used to measure how well AEZS Old manages its routine affairs as well as how well it operates its assets and liabilities.AEZS Old currently holds 277.57 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. AEZS Old has a current ratio of 9.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about AEZS Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| ScD MD | Moleculin Biotech | 73 | |
| Sina Bavari | Tonix Pharmaceuticals Holding | N/A | |
| Karen Brunke | Jaguar Animal Health | 73 | |
| Dr MBA | Tonix Pharmaceuticals Holding | 66 | |
| Marc JD | Ibio Inc | N/A | |
| Daniel MD | Transcode Therapeutics | 73 | |
| MS MD | Aditxt Inc | N/A | |
| Carol MBA | Jaguar Animal Health | 61 | |
| Peter Hodge | Jaguar Animal Health | N/A | |
| Darryl Rideout | Tonix Pharmaceuticals Holding | N/A | |
| Alan Freidman | Transcode Therapeutics | N/A | |
| RN MBA | Transcode Therapeutics | N/A | |
| John JD | Adial Pharmaceuticals | N/A | |
| Andrew Taubman | Adial Pharmaceuticals | N/A | |
| Calais Pharm | Transcode Therapeutics | 65 | |
| James MBA | Tonix Pharmaceuticals Holding | N/A | |
| Felipe Duran | Ibio Inc | 46 | |
| Thomas Englese | Tonix Pharmaceuticals Holding | 51 | |
| Dr D | Aditxt Inc | N/A | |
| MD FACP | Moleculin Biotech | 72 | |
| Catherine Collis | Jaguar Animal Health | N/A | |
Management Performance
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 |
AEZS Old Leadership Team
Elected by the shareholders, the AEZS Old's board of directors comprises two types of representatives: AEZS Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AEZS. The board's role is to monitor AEZS Old's management team and ensure that shareholders' interests are well served. AEZS Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AEZS Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Klaus Paulini, CEO President | ||
| Amlie Mtivier, Assistant Sec | ||
| Eckhard Guenther, Sr Germany | ||
| ICDD MBA, CEO President | ||
| Giuliano Fratta, Senior CFO | ||
| Matthias Gerlach, Senior Production | ||
| Nicola MD, Chief Development | ||
| Michael Teifel, Vice President - Non-Clinical Sciences |
AEZS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AEZS Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 15.15 M | |||
| Shares Outstanding | 3.06 M | |||
| Shares Owned By Insiders | 1.32 % | |||
| Shares Owned By Institutions | 5.21 % | |||
| Number Of Shares Shorted | 5.27 K | |||
| Price To Earning | 15.42 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 7.60 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |